Anne Van Hecken - Concepedia

Author

Anne Van Hecken

Also Known As

A Van Hecken, A. VAN HECKEN, A. Van Hecken, A. Van Hecken,, A. van Hecken, A.V. Van Hecken, Anne Van Hecken, Anne van Hecken

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

KU Leuven Merck & Co., Inc., Rahway, NJ, USA (United States)MSD (Belgium)United States Military Academy Universitair Ziekenhuis Leuven

About

Anne Van Hecken is an author at KU Leuven specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	16	447
2	Health Sciences	2	2	63
3	Natural Sciences	2	2	22
4	Social Sciences	2	2	27
5	Engineering	1	1	170

Anne Van Hecken

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers Anne Van Hecken, Jules I. Schwartz, Marleen Depré, The Journal of Clinical Pharmacology	2000	355
[<sup>18</sup>F]MK-9470, a positron emission tomography (PET) tracer for<i>in vivo</i>human PET brain imaging of the cannabinoid-1 receptor H. Donald Burns, Koen Van Laere, Sandra Sanabria Bohórquez, Proceedings of the National Academy of Sciences	2007	311
Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion K. Six, Tinne Daems, Jan de Hoon, European Journal of Pharmaceutical Sciences Materials ScienceEngineeringMechanical EngineeringPharmaceutical TechnologyHot-stage Extrusion	2005	170
In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232 Eric D. Hostetler, Aniket Joshi, Sandra Sanabria Bohórquez, Journal of Pharmacology and Experimental Therapeutics	2013	126
In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics Cuyue Tang, Magang Shou, Thomas H. Rushmore, Pharmacogenetics	2001	121
Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, Clinical Pharmacology & Therapeutics	2017	95
Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans Marleen Depré, Elliot Ehrich, Anne Van Hecken, European Journal of Clinical Pharmacology Drug SafetyPharmacologySupratherapeutic DosesClinical PharmacologyToxicology	2000	93
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects Thuy Vu, Peiming Ma, Jiyun Sunny Chen, Pharmaceutical Research	2017	93
Inhibition of capsaicin‐induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK‐0974) Simon Sinclair, Stefanie A. Kane, Bart Van der Schueren, British Journal of Clinical Pharmacology	2009	85
Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin M. Depré, Anne Van Hecken, Merel Oeyen, European Journal of Clinical Pharmacology ThrombosisPharmacological StudyCardiovascular DiseasePharmacodynamicsMedicine	2005	65

Page 1